Ferucarbotran

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFerucarbotran
Drug Alias NameCliavistResovistSHU-555AZK-132281BAY-864884
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMagnetic resonance imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsMyocardial InfarctionLiver Neoplasms
Global Approved IndicationsLiver Neoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritorySweden
Original Approved Date2001/01/01
Country/TerritorySwedenGermany
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active IndicationsLiver Neoplasms
Inactive IndicationsMyocardial Infarction

Other Information

ATC CodeL01XX
Related LinksKEGG